Leading ED specialist joins LTR Pharma's US advisory
Appointment supports launch of ROXUS in H1 CY26 with Pearlman to advise on medical education and prescriber engagement strategies
Special Report: LTR Pharma has announced a key appointment to its scientific advisory board as it gears up to launch its innovative nasal spray-mist to treat erectile dysfunction (ED) products in the US.
Strengthens US market entry capabilities for Roxus and SPONTAN, targeting the US$3.7 billion erectile dysfunction market
US board-certified urologist and nationally recognised leader in sexual medicine Dr Amy Pearlman has joined the LTR Pharma (ASX:LTP) scientific advisory board.
As a member of the board Pearlman will provide strategic clinical insight, medical engagement, and market access strategies for SPONTAN and ROXUS, the company's nasal spray treatments for ED.
Pearlman is co-founder of Prime Institute in Coral Gables, Florida, which is a premium private medical practice focused on optimising cardiometabolic, hormonal, and sexual health in men and women.
She is a former director of the Men's Health Program at the University of Iowa and a fellowship-trained specialist in male sexual and hormonal health.
Pearlman has trained at leading US medical institutions and built a distinguished career in sexual medicine, serving on boards and editorial panels for major professional bodies including the Sexual Medicine Society of North America and Urology Times.
An active member of the American Urological Association, she specialises in both medical and surgical management of a range of sexual health conditions for both men and women.
As a prominent voice in sexual health innovation LTR Pharma said Pearlman bought extensive expertise in ED treatment, testosterone optimisation, and comprehensive approaches to sexual wellness.
She has contributed to the Fifth International Consultation on Sexual Medicine (ICSM 2024), shaping global policy and recommendations in sexual health alongside leading international experts.
Bolstering clinical expertise for US push
Pearlman's appointment significantly enhances LTR Pharma's clinical expertise as it prepares for expansion into the US market with a deep understanding of the American healthcare landscape.
The company said her established relationships with key opinion leaders, and a proven record in advancing innovative treatments would be instrumental in positioning SPONTAN and Roxus for success in North America.
Pearlman is set to play a pivotal role in building prescriber awareness for the company's rapid-onset ED treatments.
Her thought leadership is widely recognised through national media appearances, conference presentations, and her popular podcast Pearls and Perspectives.
Pearlman has been honoured with international professorships and is frequently invited as a keynote speaker at major urological and sexual medicine conferences globally.
'Compelling alternative' to current treatments
Pearlman said she believed SPONTAN and ROXUS would be important additions to treatment options in the US for men seeking effective, rapid-onset ED treatment.
'The intranasal delivery platform offers a compelling alternative to current oral medications, providing onset of action in 10 minutes or less with an excellent safety profile,' she said.
'Having dedicated my career to advancing sexual health and wellness, I'm thrilled to join LTR Pharma's scientific advisory board and contribute to bringing these innovative treatments to American patients who deserve better options for spontaneous intimacy."
LTR Pharma executive chairman Lee Rodne said the company was honoured to welcome Pearlman to its scientific advisory board.
'Her recognised expertise in sexual medicine, combined with her innovative approach to patient care and treatment, makes her an invaluable addition to our team.
Rodne said Pearlman's appointment is a critical milestone in the company's US market entry strategy, with ROXUS planned for launch in H1 CY26.
'Her relationships with prescribers and her influential position within the American urological and sexual health community will be crucial as we build momentum in the world's largest pharmaceutical market,' he said.
'Her appointment underscores our commitment to assembling world-class expertise to deliver innovative treatments for erectile dysfunction."
This article was developed in collaboration with LTR Pharma, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Perth Now
an hour ago
- Perth Now
‘Critical': Big AUKUS call amid Trump fears
AUKUS is 'critical' to Australia's defence, Assistant Defence Minister Peter Khalil has declared while spruiking it in Adelaide with visiting US congressmen. US representatives Joe Courtney and Trent Kelly are in Australia for the Australian American Leadership Dialogue – an annual conference aimed at highlighting the deep ties between Canberra and Washington. Both men are staunch supporters of the US-Australia alliance, including AUKUS, which the Trump administration is reviewing. Speaking to media, Mr Kelly, a Republican like Donald Trump, said the bilateral relationship was like no other. 'Our relationship with our Australian partners is one that cannot be can't be replicated,' he told reporters, standing alongside Mr Khalil and South Australian Premier Peter Malinauskas. 'And so it's important that we continue to grow as friends. 'I've seen that relationship over the last two or three years as AUKUS has matured, grow stronger and better.' Republican congressman Trent Kelly says the US-Australia relationship 'can't be replicated'. Naomi Jellicoe Credit: News Corp Australia Mr Kelly was speaking from Osborne Naval Shipyard, where five nuclear-power AUKUS submarines will be built, assuming the US stays in the defence pact. More than $1.5 billion in federal funds have already been pumped into preparing to build and maintain them. Australia will also get at least three American-made Virginia-class submarines under the agreement. Mr Khalil said the Albanese government welcomed the Trump administration's review, declaring it 'brings forward the issues that are actually important for us to discuss about how we can get the best out of this partnership'. 'The AUKUS partnership is something that is historic,' he said. 'It's critical, it's important.' He went on to say the 'advanced capability that we get out of the Virginia-class and the future AUKUS submarines is extremely important'. 'We're talking about making sure that we have the ADF and the defence capability to deter and deny adversaries from impacting negatively our national interests, forcing others to come back to the negotiating table rather than using force,' Mr Khalil said. 'Investment in defence is about investment in peace.' Assistant Defence Minister Peter Khalil says AUKUS is an 'investment in peace'. Naomi Jellicoe Credit: News Corp Australia US President Donald Trump's defence policy chief Elbridge Colby announced he was delaying the AUKUS review late last month and did not give a firm date for its completion. Instead, Mr Colby, an AUKUS sceptic, said the review would be completed 'in the fall' – much longer than the initial 30 days. The delay comes as the Albanese government resists Washington's demand to hike defence spending to 3.5 per cent of GDP in response to China's rapid military build-up. Announcing the delay, Mr Colby's office said the AUKUS review would 'be an empirical and clear-eyed assessment of the initiative's alignment with President Trump's America First approach'. 'As part of this process, the (US Department of Defence) looks forward to continuing regular engagements on this important matter with other parts of the US government, the US Congress, our allies Australia and the United Kingdom and other key stakeholders,' his office said. 'The department anticipates completing the review in the fall. 'Its purpose will be to provide the President and his senior leadership team with a fact-based, rigorous assessment of the initiative.'
ABC News
2 hours ago
- ABC News
Concerns over TikTok birth control content
Andy Park: Well, you'll probably agree that you can do better than get health advice from social media. Now, doctors say concerning even harmful misinformation about birth control is getting around. A recent study of 100 TikTok videos about contraception found that more than half rejected hormonal birth control methods like the pill, patch or IUDs. Many promoted so-called natural forms of birth control without disclosing the risk. Bridget Fitzgerald has more. Bridget Fitzgerald: Spend a couple of minutes on social media and you'll be bombarded with lots of opinions about birth control. Opinion: Is it true that the birth control pill? You know, the other thing about birth control too, this is crazy. I've been off birth control for a week and a half after being on it for 15 years. I don't know who needs to hear this, but you do not need a break from your birth control. Bridget Fitzgerald: And much like any other medical topic, most of it is based on thoughts and feelings rather than science. Dr Sara Whitburn is the medical director at Sexual Health Victoria. Dr Sara Whitburn: I think social media is there to validate people's experiences. However, when we're talking about contraception choice, we often talk about broad ranges of experiences and basing that in evidence and trying to give people both the pros and the cons of contraception. Bridget Fitzgerald: She says young people are using social media to learn about contraception. Dr Sara Whitburn: It is now being used as a search engine and it's now how people get their information. So I'm certainly not against using social media to get information, but I think it's about thinking about our digital literacy and also about how we assess or interact with things that are on social media. Bridget Fitzgerald: In a recent study published in the journal Perspectives on Sexual and Reproductive Health, an analysis of 100 TikTok videos found 53% of them rejected the use of hormonal birth control. The most frequently discussed topics were fertility awareness and cycle tracking, followed by videos about the pill. Dr Caroline de Moel is the lead researcher. Dr Caroline de Moel: Much of the information provided by the uploaders were based on personal experiences and beliefs, and they contained non-medical advice rather than medical evidence. Bridget Fitzgerald: Dr de Moel says often when content creators promote natural methods of birth control, such as cycle tracking, they failed to point out their limitations or that if used alone, they're often ineffective. She says about a third of videos analysed expressed broad distrust in medical professionals and with the health system. Dr Caroline de Moel: It is an alarming trend. People sort of choose to distrust their health professionals and look for TikTok instead for health information. And that's quite worrying. Bridget Fitzgerald: But broad concerns about the effects of hormonal contraception are not just isolated to social media. Professor Danielle Mazza is the director of the Sphere Centre of Research Excellence in Women's Sexual and Reproductive Health in Primary Care. Prof Danielle Mazza: Increasingly, there's a lot of misinformation appearing on social media of all kinds. And it corresponds with a trend towards decreasing use of hormonal contraception, particularly by young women, which is a worldwide phenomenon and quite a scary one in terms of health outcomes for women. Bridget Fitzgerald: Danielle Mazza says it isn't exactly clear why women are turning away from hormonal birth control, but it's associated with a lack of information and broader distrust in medicine, and it increases the risk of unplanned pregnancy. She says despite the trend, things like the pill or IUDs are largely safe. Prof Danielle Mazza: They've been used by millions of women around the world for many, many years now. And these products have a range of benefits and some risks. And it's very important for women to receive person-centred care, which takes into account their individual needs and individual health profiles when deciding on what form of contraception is best for them. And the best place to do that is with a healthcare professional that is highly trained to deliver this kind of care. Bridget Fitzgerald: And for those that prefer social media, just check the source. Dr Sara Whitburn says there's plenty of medical and expert content out there with good advice. Dr Sara Whitburn: Sexual Health Victoria and some GPs and University of Melbourne have some really great evidence-based TikToks to try and support people to find information in a place that is comfortable and useful for them. Andy Park: Dr Sara Whitburn from Sexual Health Victoria, ending that report by Bridget Fitzgerald.
News.com.au
2 hours ago
- News.com.au
Break it Down: Orthocell's Remplir builds strong US market momentum
Orthocell's nerve repair product Remplir is continuing its strong US market momentum with increasing surgical adoption.
